CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Exelixis, Inc.  (EXEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 
 

EXEL's Revenue Year on Year Growth by Quarter and Year

Exelixis,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
EXEL Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 77.58 9.94 7.35
III Quarter September - 62.19 9.85 6.29
II Quarter June 99.01 36.25 7.99 6.56
I Quarter March 80.89 15.43 9.39 4.91
FY   179.90 191.45 37.17 25.11

Financial Statements
Exelixis,'s second quarter 2017 Revenue $ 99.01 millions EXEL's Income Statement
Exelixis,'s second quarter 2016 Revenue $ 36.25 millions Quarterly EXEL's Income Statement
EXEL's Growth by Division See EXEL's Growth by Segment

EXEL Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 680.48 % 35.24 % 950 %
III Quarter September - 531.37 % 56.6 % 14.99 %
II Quarter June 173.13 % 353.69 % 21.8 % -44.69 %
I Quarter March 424.24 % 64.32 % 91.24 % -37.13 %
FY   - 415.07 % 48.03 % -



EXEL Revenue Growth Comment
Exelixis, Inc. reported Revenue surge of 173.13% year on year in the second quarter, to $ 99.01 millions, this is lower than Exelixis, Inc.'s recent average Revenue surge of 203.15%.

Among companies who have reported second quarter results in the Medical Laboratories industry only one Company has achieved higher year on year Revenue results in the second quarter. While Exelixis, Inc.' s Revenue doubling of 173.13% ranks overall at the positon no. 162 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #40
Overall #162
Revenue Y/Y Growth Statistics
High Average Low
945.95 % 203.15 % -91 %
(Jan 02 2015)   (Dec 27 2013)

You need to upgrade your Flash Player

Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EXEL's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for EXEL's Competitors
Revenue Growth for Exelixis,'s Suppliers
Revenue Growth for EXEL's Customers

You may also want to know
EXEL's Annual Growth Rates EXEL's Profitability Ratios EXEL's Asset Turnover Ratio EXEL's Dividend Growth
EXEL's Roe EXEL's Valuation Ratios EXEL's Financial Strength Ratios EXEL's Dividend Payout Ratio
EXEL's Roa EXEL's Inventory Turnover Ratio EXEL's Growth Rates EXEL's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Zogenix, Inc.  241.24 %$ 241.236 millions
Steadymed Ltd.  239.36 %$ 239.362 millions
Arbutus Biopharma Corp  236.25 %$ 236.246 millions
Apollo Medical Holdings, Inc.  236.05 %$ 236.054 millions
Neos Therapeutics, Inc.  230.57 %$ 230.572 millions
Inovio Pharmaceuticals, Inc.  229.03 %$ 229.027 millions
Chemocentryx, Inc.  219.75 %$ 219.750 millions
Ptc Therapeutics, Inc.  206.80 %$ 206.800 millions
Bellicum Pharmaceuticals, Inc.  203.96 %$ 203.960 millions
Cti Biopharma Corp.  201.93 %$ 201.929 millions
Orexigen Therapeutics, Inc.  199.78 %$ 199.782 millions
Enzon Pharmaceuticals, Inc.  198.20 %$ 198.195 millions
Cytomx Therapeutics, Inc.  182.87 %$ 182.870 millions
Regenxbio Inc.  176.29 %$ 176.295 millions
Hci Viocare  175.23 %$ 175.234 millions
American Cryostem Corp  172.48 %$ 172.478 millions
Exact Sciences Corp  172.11 %$ 172.108 millions
Ionis Pharmaceuticals Inc  170.74 %$ 170.736 millions
Novavax Inc  168.74 %$ 168.743 millions
Amyris, Inc.  167.52 %$ 167.517 millions
Invitae Corp  156.87 %$ 156.872 millions
Biolargo, Inc.  156.45 %$ 156.446 millions
Lifestyle Medical Network, Inc.  153.16 %$ 153.158 millions
Rewalk Robotics Ltd.  145.65 %$ 145.655 millions
Viewray, Inc.  133.44 %$ 133.445 millions
Psivida Corp.  130.59 %$ 130.592 millions
Second Sight Medical Products Inc  115.62 %$ 115.622 millions
American Cannabis Company, Inc.  114.76 %$ 114.760 millions
Novocure Ltd  114.16 %$ 114.164 millions
Geovax Labs, Inc.  111.77 %$ 111.774 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EFC's Profile

Stock Price

EFC's Financials

EFC's Expectations

Business Description

Fundamentals

Charts & Quotes

EFC's News

Suppliers

EFC's Competitors

Customers & Markets

Economic Indicators

EFC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com